INS and type 1 diabetes mellitus: STZ is a nitrosourea analogue that enters pancreatic beta cells via the GLUT2 transporter to ablate beta cells and cause the subsequent loss of insulin production by the pancreas in a manner mechanistically similar to type-1 diabetes mellitus (T1DM)18.